| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TRANSGENOMIC INC | 7,550,669 | 2,114,000 | 0.10% | ||
| 2 | AMPLIPHI BIOSCIENCES CORP | 1,587,359 | 2,412,000 | 0.11% | ||
| 3 | OVASCIENCE INC COM | 373,224 | 2,672,000 | 0.12% | ||
| 4 | ENERGY TRANSFER PRTNRS L P | 85,135 | 3,150,000 | 0.15% | ||
| 5 | TC PIPELINES LP | 97,000 | 5,532,000 | 0.26% | ||
| 6 | NUSTAR ENERGY LP | 116,500 | 5,776,000 | 0.27% | ||
| 7 | ORAGENICS INC COM NEW | 15,481,644 | 7,121,000 | 0.33% | ||
| 8 | GENESIS ENERGY LP COM UNITS NPV | 217,000 | 8,239,000 | 0.38% | ||
| 9 | HISTOGENICS CORP | 2,690,570 | 8,637,000 | 0.40% | ||
| 10 | FIBROCELL SCIENCE INC | 16,620,414 | 11,967,000 | 0.56% | ||
| 11 | ENERGY TRANSFER L P | 752,400 | 12,633,000 | 0.59% | ||
| 12 | SYNTHETIC BIOLOGICS INC | 13,238,268 | 22,770,000 | 1.06% | ||
| 13 | ENTERPRISE PRODS PARTNERS L | 1,035,834 | 28,620,000 | 1.33% | ||
| 14 | ZIOPHARM ONCOLOGY INC | 9,692,403 | 54,568,000 | 2.54% | ||
| 15 | HALOZYME THERAPEUTICS INC | 19,305,403 | 233,209,000 | 10.86% | ||
| 16 | INTREXON CORP | 62,029,052 | 1,738,054,000 | 80.93% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-086429, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
